Atlas Opportunity Score: 76/100
N9+ Fit Score: 0/100
Opportunity Summary
Official opportunity: Childhood Cancer Research 2027
Issuer: Illinois Department of Public Health
CSFA: 482-00-3646
Agency opportunity number: N/A in the current FY2027 NOFO.
Funding: The FY2027 NOFO lists one anticipated award of $38,792.05.
Match: None required.
Deadline: September 18, 2026 at 4:30 p.m. The current NOFO does not separately state a time zone.
Deadline-source note: The Illinois GATA program page contains a general Deadlines field showing September 14, 2026, but that same page’s current FY2027 NOFO listing and the FY2027 NOFO itself state September 18, 2026 at 4:30 p.m. Atlas treats the current NOFO date and time as controlling.
Purpose and Eligibility
The program supports biomedical, technical, or psychosocial research concerning childhood cancer. Eligible topics may include epidemiology, etiology, pathology, social or economic impacts, in-home care, and psychosocial issues. Awards are available only for Illinois researchers, with the recipient required to be an institution rather than an individual. Eligible applicant types include nonprofit corporations, government entities, and universities/community colleges, subject to the full FY2027 NOFO and GATA requirements. Proposed work must be designed for completion by June 30, 2027.
Application Requirements
Applicants must satisfy Illinois GATA registration and prequalification requirements, including active UEI and SAM registrations and applicable fiscal/good-standing/exclusion checks. Applications must be completed in the IDPH EGrAMS system before 4:30 p.m. on September 18, 2026. Required materials include the Uniform State Grant Application, project narrative, budget, budget narrative, work plan, biographical sketches or CVs, and a subcontractor disclosure form when applicable.
Scoring and Funding Restrictions
The NOFO allocates 60 points to Scope of Work, 20 to Work Plan, 15 to Budget, and 5 to Miscellaneous criteria. Equipment is expressly unallowable, as are prescription drugs, land/building acquisition or improvement, facility leases, airfare, out-of-state travel, and other prohibited costs listed in the NOFO. Quarterly program and reimbursement reporting is required.
Dr. Miltie / N9+ Fit
N9+ is not a legitimate fit for this research-only opportunity. The NOFO expressly prohibits equipment costs, so Atlas is not forcing a telehealth or remote physical-examination component into the grant.
Controlling Sources
Illinois GATA/CSFA Program Record
IDPH EGrAMS
Applicants should verify the current controlling NOFO and any amendments in EGrAMS before submission.